Moreover, the thiol-disulfide reduction in COVID-19 patients might be related to an enhanced inflammation via NF-κB activation [33]; however, only a weak correlation with Tri-DAP inducing IL-8 secretion and total thiols was observed, suggesting that the primary pathway is through receptor agonists. This evidence concerns the gene NFKB1 and COVID-19.